Vivus submits obesity drug to FDA - Bizjournals.com

[INCIID News Feed]

RTT News
<img alt="" height="1" width="1" />
Vivus submits obesity drug to FDA
Bizjournals.com
After wrapping up two recent year-long Phase III tests of its obesity drug Qnexa, Vivus Inc. asked the Food and Drug Administration to OK it for sale. Mountain View-based Vivus (NASDAQ: VVUS) found in clinical testing that the drug helped patients lose ...
Vivus says it asked FDA for marketing approval of its obesity drug candidate QnexaLos Angeles Times
VIVUS Files With FDA For Obesity Drug QnexaRTT News
Vivus files marketing application for obesity drugReuters
FOXBusiness -NASDAQ -MSN Money
all 99 news articles &raquo;


More...